Nutex Health, INC Form 4 insider transactions

Frank E Jaumot, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.

Cheryl Yvonne Grenas, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.

Scott J Saunders, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.

Michael Lee Reed, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.

Nutex Health Inc. Director Kelvin Spears reported the acquisition of 2,519 shares of common stock on June 4, 2026, as part of a private transaction related to prior merger obligations.

Nutex Health CEO Thomas T. Vo acquired 75,747 shares of common stock through an indirect holding entity.

Director Michael Lee Reed was granted 823 restricted stock units as part of his compensation package with Nutex Health Inc.

Nutex Health Inc. Director Scott J. Saunders was granted 823 Restricted Stock Units, vesting fully on April 23, 2027.

Nutex Health Inc. Director Frank E. Jaumot received a grant of 823 Restricted Stock Units, vesting 100% on April 23, 2027.

Nutex Health Inc. director Cheryl Yvonne Grenas was granted 823 Restricted Stock Units (RSUs) on April 23, 2026, vesting fully on April 23, 2027.

Nutex Health Inc. CEO Thomas T. Vo reported a transaction involving common stock and restricted stock units, adjusting his beneficial ownership.

Nutex Health Inc.'s Chief Operating Officer, Wesley Shane Bamburg, was granted 2,411 Restricted Stock Units, vesting in three annual installments.

Nutex Health President Warren Hosseinion acquired common stock and corrected a previous filing regarding restricted stock units.

Nutex Health Director and 10% Owner Frank E. Jaumot reported the purchase of 150 shares of common stock at $93.555 per share, effective March 20, 2026.

Nutex Health's Chief Legal Officer-Healthcare, Pamela W. Montgomery, filed a Form 4 to correct previously reported Restricted Stock Units and disclose a recent common stock purchase.

Nutex Health Inc. Director Scott J. Saunders received a grant of 603 Restricted Stock Units, with the filing significantly delayed.

Nutex Health Director Michael Lee Reed was granted 603 Restricted Stock Units, which are set to vest fully on July 14, 2026.

Nutex Health director Cheryl Yvonne Grenas was granted 603 Restricted Stock Units (RSUs) on July 14, 2025, which vest on July 14, 2026, with the Form 4 filing occurring significantly after the transaction date.

Nutex Health Inc. Director Frank E. Jaumot received a grant of 603 Restricted Stock Units, vesting fully on July 14, 2026.

Nutex Health, Inc.'s Chief Financial Officer, Jon Christian Bates, purchased 750 shares of common stock at $136.7099 per share.

Jon Christian Bates, CFO of Nutex Health, Inc., reports acquisition and disposal of common stock and restricted stock units.

Director Kelvin Spears of Nutex Health, Inc. reports acquisition and disposal of common stock and restricted stock units.

Joshua DeTillio, Chief Operating Officer of Nutex Health, Inc., reports the vesting and subsequent sale of shares to cover tax obligations.

Pamela Montgomery, Chief Legal Officer-Healthcare at Nutex Health, Inc., reports acquisition and disposal of common stock and restricted stock units.

Michael L. Chang, Chief Medical Officer of Nutex Health, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

CEO Thomas Vo reports acquisition and disposal of Nutex Health stock, including transactions related to restricted stock units and tax obligations.

Warren Hosseinion, President of Nutex Health, Inc., reports the vesting and subsequent sale of shares to cover tax obligations.

Chief Legal Officer Elisa Luqman reports acquisition and disposal of Nutex Health stock and restricted stock units.

Nutex Health CEO, Thomas T. Vo, indirectly acquired 5,000 shares of common stock on January 8, 2025, through entities he controls.

Jon Christian Bates, CFO of Nutex Health, Inc., reported the purchase and disposal of common stock on August 22, 2024.